SCHEMBL3540132

SCHEMBL3540132

CCC(C)C(=Cc1cccc(OC)c1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
MAPT P10636 3/20 0.46
FOS P01100 1/20 0.46
JUN P05412 1/20 0.46
BCHE P06276 1/20 0.46
GRIK1 P39086 1/20 0.44
GRIK2 Q13002 1/20 0.44
MAOB P27338 2/20 0.43
LMNA P02545 3/20 0.42
KDM4E B2RXH2 2/20 0.42
GLO1 Q04760 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RELA Q04206 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5319436 0.86 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL4861174 0.86 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL3544381 0.77 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL3544382 0.77 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL3549405 0.77 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL16160151 0.77 MEN1 (0.54) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL11811000 0.77 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL30560128 0.76 MEN1 (0.68) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL7821958 0.76 MEN1 (0.68) ALDH1A1MEN1KMT2AMAPTFOS
SCHEMBL7821956 0.76 MEN1 (0.68) ALDH1A1MEN1KMT2AMAPTFOS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652041-B2 4-[4-(3-oxo-3-{[3-(trifluoromethyl)phenyl]amino}propyl)phenoxy]pyridino-2-carboxamido: N-methyl-4-[4-(3-oxo-3-{[3-(trifluoromethyl)phenyl]amino}propyl)phenoxy]pyridine-2-carboxamide: Raf-kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-01-26 US disclosed
US-20060160803-A1 Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160803-A1 Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity MAP3K21, HIPK4, MAP3K20 ALDH1A1 2863/4885MEN1 2134/4885KMT2A 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.